Aptose Biosciences
APTO
#10465
Rank
ยฃ3.27 M
Marketcap
ยฃ1.28
Share price
0.00%
Change (1 day)
718.60%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -ยฃ16.16 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ18.95 Million, an increase over its 2023 earnings that were of -ยฃ39.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ16.16 Million-14.7%
2024 -ยฃ18.95 Million-51.82%
2023 -ยฃ39.32 Million22.9%
2022 -ยฃ32 Million-34.91%
2021 -ยฃ49.15 Million17.36%
2020 -ยฃ41.88 Million107.65%
2019 -ยฃ20.17 Million-7.73%
2018 -ยฃ21.86 Million160.68%
2017 -ยฃ8.39 Million-20.27%
2016 -ยฃ10.52 Million28.71%
2015 -ยฃ8.18 Million
2013 -ยฃ4.64 Million
2010 -ยฃ3.95 Million-8.31%
2009 -ยฃ4.31 Million
2006 -ยฃ7.98 Million-156.93%
2005 ยฃ14.01 M-185.16%
2004 -ยฃ16.46 Million458.58%
2003 -ยฃ2.95 Million-63.66%
2002 -ยฃ8.11 Million-8.04%
2001 -ยฃ8.82 Million16.73%
2000 -ยฃ7.56 Million294.99%
1999 -ยฃ1.92 Million-6.51%
1998 -ยฃ2.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-ยฃ25.55 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-ยฃ43.24 Million 175.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-ยฃ47.15 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA